Skip to main content

Xgeva 120 mg/1.7 mL injection Images

Generic Name: denosumab

This medication has been identified as Xgeva 120 mg/1.7 mL injection. It is supplied by Amgen Inc.

Xgeva is used in the treatment of Osteolytic Bone Metastases of Solid Tumors; Giant Cell Tumor of Bone; Osteolytic Bone Lesions of Multiple Myeloma; Hypercalcemia of Malignancy and belongs to the drug class miscellaneous bone resorption inhibitors. Not for use in pregnancy. Xgeva 120 mg/1.7 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Xgeva 120 mg/1.7 mL injection medicine


Generic Name
120 mg/1.7 mL injection
Prescription only
Drug Class
Miscellaneous bone resorption inhibitors
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amgen Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.